MEPSHP and LVPA Joint Meeting
Map this EventMap this Event Tell a Friend About This EventTell a Friend
 

RSVP by Wednesday, September 20th

 Export to Your Calendar 9/27/2017
When: Tuesday, September 27, 2016
6:00 PM
Where: Map this event »
Blue Grillhouse
4431 Easton Ave
Bethlehem, Pennsylvania  18020
United States

« Go to Upcoming Event List  

Details

The Mid-Eastern Chapter of the Pennsylvania Society of Health-System Pharmacists, the Lehigh Valley Pharmacists’ Association and Sanofi U.S. would like to invite you to the next dinner/meeting on Wednesday, September 27th.

Blue Grillhouse
4431 Easton Ave, Bethlehem, PA 18020

Please RSVP by Wednesday, September 20th, and if you need to cancel, please contact Jeneane Acker for PSHP members or Howard Cook for PPA members by Tuesday, September 25th.

 

Agenda

6pm – 6:30pm: Registration
6:30pm – 7:30pm: Dinner and Promotional Presentation
7:30pm – 7:45pm: Break
7:45pm – 8:45pm: Educational Presentation

 

Promotional Presentation:

Topic: “Understanding the treatment of Diabetes”
Product: Toujeo
Speaker: Sumon Agarwala, MD

 

Educational Presentation:

Injecting Change is an Insul-win
Speaker: Nicole Pezzino, PharmD, CDE, Assistant Professor, Wilkes University

Target Audience: All Pharmacists

CE Credit: 1 Contact Hour (0.1 CEU)

Program Objectives: At the completion of this activity, the participant will be able to:
1. Compare and contrast the new insulin therapies including their equivalent mechanisms
2. Describe a place in therapy for the new insulin therapies
3. Apply the information on new insulin therapies to a patient case

Description: Significant advances have developed in the management of diabetes, including an increase in options of insulin therapies for our patients. The speakers will be discussing six of the most recent insulin therapies: Afrezza® (inhaled insulin), Toujeo® (insulin glargine U-300), Tresiba® (insulin degludec), Ryzodeg 70/30 (insulin degludec and insulin aspart), Basaglar® (insulin glargine) and FIAsp (ultra-rapid acting formulation of Novolog). Topics to be covered for each insulin include: efficacy/safety trials, PK/PD profiles, pen differences (units/pen, days stable unrefrigerated, max dose in a single injection, "hold" injection seconds). To conclude the session, participants will be asked to apply the information to a patient case where we will identify key methods of personalizing the insulin regimens to meet the patient's individual routine.

Activity Type: Application-based

UAN: 0159-0000-17-023-L01-P

Registration

Cost:

  • PPA Members and PSHP Members - Free
  • Non-Member Pharmacists: $25
  • Non-Member Techs, Students and Residents: $5

Limit 30 MEPSHP and 30 LVPA (Max total: 60 people)

Please RSVP by Wednesday, September 20th, and if you need to cancel, please contact Jeneane Acker for PSHP members or Howard Cook for PPA members by Tuesday, September 25th.


 

The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Successful completion requires evaluation of each session attended. The evaluation form must be completed and returned at the conclusion of the program. NABP ID number and date of birth (MM/DD only) are required to receive credit for the program.  Further information can be obtained at http://www.nabp.net/programs/cpe-monitor/cpe-monitor-service/